Table of Contents Author Guidelines Submit a Manuscript
Retracted

BioMed Research International has retracted this article. Figures 1(a) and 1(b) show identical gels other than the part of the right-hand lane that includes the band of interest in Figure 1(b).

View the original article here.

References

  1. C.-Q. Tan, X. Gao, W.-J. Cai, X.-Y. Qian, L. Lu, and H. Huang, “Experimental study of local inner ear gene therapy for controlling autoimmune sensorineural hearing loss,” BioMed Research International, vol. 2014, Article ID 134658, 10 pages, 2014.
BioMed Research International
Volume 2014 (2014), Article ID 134658, 10 pages
http://dx.doi.org/10.1155/2014/134658
Research Article

Experimental Study of Local Inner Ear Gene Therapy for Controlling Autoimmune Sensorineural Hearing Loss

1State Key Laboratory of Materials-Oriented Chemical Engineering, College of Biotechnology and Pharmaceutical Engineering, Nanjing University of Technology, No. 5 Xinmofan Road, Nanjing, Jiangsu 210009, China
2Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Jiangsu 210008, China
3Department of Otolaryngology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu 210009, China

Received 16 October 2013; Revised 24 January 2014; Accepted 3 March 2014; Published 7 April 2014

Academic Editor: Claus-Peter Richter

Copyright © 2014 Chang-qiang Tan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. F. McCabe, “Autoimmmne semorineural hearing loss,” Annals of Otology, Rhinology, and Laryngology, vol. 88, pp. 585–589, 1979. View at Google Scholar
  2. B. F. McCabe, “Autoimmune inner ear disease: therapy,” American Journal of Otology, vol. 10, no. 3, pp. 196–197, 1989. View at Google Scholar · View at Scopus
  3. A. K. Lalwani, B. J. Walsh, P. G. Reilly, N. Muzyczka, and A. N. Mhatre, “Development of in vivo gene therapy for hearing disorders: introduction of adeno-associated virus into the cochlea of the guinea pig,” Gene Therapy, vol. 3, no. 7, pp. 588–592, 1996. View at Google Scholar · View at Scopus
  4. Y. Raphael, J. C. Frisancho, and B. J. Roessler, “Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivo,” Neuroscience Letters, vol. 207, no. 2, pp. 137–141, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Fukui and Y. Raphael, “Gene therapy for the inner ear,” Hearing Research, vol. 297, pp. 99–105, 2013. View at Publisher · View at Google Scholar
  6. T. Jansen, B. Tyler, J. L. Mankowski et al., “FasL gene knock-down therapy enhances the antiglioma immune response,” Neuro-Oncology, vol. 12, no. 5, pp. 482–489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Jin, A. Qu, G. M. Wang, J. Hao, X. Gao, and S. Xie, “Simultaneous stimulation of Fas-mediated apoptosis and blockade of costimulation prevent autoimmune diabetes in mice induced by multiple low-dose streptozotocin,” Gene Therapy, vol. 11, no. 12, pp. 982–991, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. H.-G. Zhang, J. D. Mountz, M. Fleck, T. Zhou, and H.-C. Hsu, “Specific deletion of autoreactive T cells by adenovirus-transfected, Fas ligand-producing antigen-presenting cells,” Immunologic Research, vol. 26, no. 1–3, pp. 235–246, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Bulfone-Paus, R. Rückert, H. Krause et al., “An interleukin-2-IgG-Fas ligand fusion protein suppresses delayed-type hypersensitivity in mice by triggering apoptosis in activated T cells as a novel strategy for immunosuppression,” Transplantation, vol. 69, no. 7, pp. 1386–1391, 2000. View at Google Scholar · View at Scopus
  10. F. Batteux, L. Tourneur, H. Trebeden, J. Charreire, and G. Chiocchia, “Gene therapy of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for Fas ligand,” Journal of Immunology, vol. 162, no. 1, pp. 603–608, 1999. View at Google Scholar · View at Scopus
  11. R. Matsuda, T. Kezuka, C. Nishiyama et al., “Interleukin-10 gene-transfected mature dendritic cells suppress murine experimental autoimmune optic neuritis,” Investigative Ophthalmology and Visual Science, vol. 53, no. 11, pp. 7235–7245, 2012. View at Publisher · View at Google Scholar
  12. A.-J. Xu, W. Zhu, F. Tian, L.-H. Yan, and T. Li, “Recombinant adenoviral expression of IL-10 protects beta cell from impairment induced by pro-inflammatory cytokine,” Molecular and Cellular Biochemistry, vol. 344, no. 1-2, pp. 163–171, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. P. B. Thomas, D. M. Samant, S. Selvam et al., “Adeno-associated virus-mediated IL-10 gene transfer suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis,” Investigative Ophthalmology and Visual Science, vol. 51, no. 10, pp. 5137–5144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. E. E. Hillhouse, C. Beauchamp, G. Chabot-Roy, V. Dugas, and S. Lesage, “Interleukin-10 limits the expansion of immunoregulatory CD4 CD8 T cells in autoimmune-prone non-obese diabetic mice,” Immunology and Cell Biology, vol. 88, no. 8, pp. 771–780, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Yagi, E. Magal, Z. Sheng, K. A. Ang, and Y. Raphael, “Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor,” Human Gene Therapy, vol. 10, no. 5, pp. 813–823, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Husseman and Y. Raphael, “Gene therapy in the inner ear using adenovirus vectors,” Advances in Oto-Rhino-Laryngology, vol. 66, pp. 37–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Tan, Y. Cao, and P. Hu, “The experimental research of inner ear metabolism and electrical physiology of autoimmune sensorineural hearing loss,” Lin Chuang Er Bi Yan Hou Ke Za Zhi, vol. 12, no. 9, pp. 407–410, 1998. View at Google Scholar · View at Scopus
  18. F. A. J. van de Loo and W. B. van den Berg, “Gene therapy for rheumatoid arthritis: lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators,” Rheumatic Disease Clinics of North America, vol. 28, no. 1, pp. 127–149, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Yu, S. H. Venkatesha, and K. D. Moudgil, “Microarray-based gene expression profiling reveals the mediators and pathways involved in the anti-arthritic activity of celastrus-derived celastrol,” International Immunopharmacology, vol. 13, no. 4, pp. 499–506, 2012. View at Publisher · View at Google Scholar
  20. W. Zhang, F. Wang, B. Wang, J. Zhang, and J. Y. Yu, “Intraarticular gene delivery of CTLA4-FasL suppresses experimental arthritis,” International Immunopharmacology, vol. 24, no. 6, pp. 379–388, 2012. View at Publisher · View at Google Scholar
  21. Y. Liu, G. Wang, A. Shen et al., “Construction of recombinant adenovirus and mediated reported gene expression in the guinea pig cochlea,” Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, vol. 21, no. 16, pp. 748–751, 2007. View at Google Scholar · View at Scopus